AGS-5-ME

N/A

Report date: 2024/02/05 14:09:11

Base Information

Drug NameAGS-5-ME
Drug Alias NameAGS-5-MEASG-5-MEASG-5ME
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Linker > Cleavable linker > VC linkerBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > MMAE payloadBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionTubulin polymerisation inhibitorsAnti-CTL4
TargetsCholine transporter-like protein 4Tubulin
Therapy Area/IndicationsProstatic NeoplasmsPancreatic NeoplasmsStomach Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSeagen IncAgensys Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSeagen IncAstellas Pharma IncAgensys Inc
Active IndicationsN/A
Inactive IndicationsProstatic NeoplasmsPancreatic NeoplasmsStomach Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A